Exclusives Archives - Page 59 of 102

3 minute read

EXCLUSIVE: Top 10 Most-Searched Tickers On Benzinga Pro In April, Including Tesla, First Republic Bank And Several AI Stocks

May 6, 2:37 PM

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

AAPL

3 minute read

EXCLUSIVE: DraftKings Benefits From Non-NFL Sports Growth, Eyes Horse Racing And Election Betting Expansion

By Chris Katje

May 5, 4:01 PM

Strong launches in Ohio and Massachusetts, customer retention and market share wins are giving DraftKings Inc (NASDAQ: DKNG) the confidence to raise full-year guidance<

CHDN

3 minute read

EXCLUSIVE: DraftKings CEO Sizes Up Sports Betting Competition: ‘Always Good To Understand How Your Competitors Are Doing’

By Chris Katje

May 5, 2:26 PM

Sports betting company DraftKings Inc (NASDAQ: DKNG) reported first quarter financial results and raised guidance for the full year Thursday.

DKNG

2 minute read

EXCLUSIVE: DraftKings CEO Says ‘We’re Seeing Really Strong Trends’ After Q1 Beat, Guidance Raise

By Chris Katje

May 5, 1:27 PM

Strong launches in Ohio and Massachusetts, customer retention and market share wins are giving DraftKings Inc (NASDAQ: DKNG) the confidence to raise full-year guidance in the

CHDN

3 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

By Chris Katje

May 4, 4:13 PM

Investors are on the hunt for undervalued, underfollowed and emerging stocks and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

ASNS

1 minute read

EXCLUSIVE: Digital Brands Expects Q1 Revenues To Jump 46%

By Vandana Singh

May 4, 8:00 AM

Digital Brands Group Inc (NASDAQ: DBGI) expects Q1 FY23 revenues to be approximately $5.0 million, an increase of 46.5% year-over-year.

DBGI

1 minute read

EXCLUSIVE: SAB Biotherapeutics’ Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials

By Vandana Singh

May 4, 8:00 AM

SAB Biotherapeutics Inc (NASDAQ: SABS) has announced the presentation of safety and efficacy data from Phase 1 and 2a trials of its influenza immunotherapy, SAB-176.

RHHBY

3 minute read

Zappy Zapolin Talks Psychedelics And Breakthrough Delivery Methods: The Future Has Arrived And It’s Awesome

By Maureen Meehan

May 3, 9:23 AM

Mike ‘Zappy’ Zapolin, Chief Visionary Officer of Psycheceutical Bioscience, Inc (OTCPK: BWVI), whom we'll call Zappy, shared his vision for the future of psychedelics at the recent Benzinga Psychedelics Capital Conference in Miami.

BWVI

3 minute read

EXCLUSIVE: FanDuel Parent Flutter Gets Dual Listing, Giving Investors ‘Another Way To Gain Exposure’ To An Industry Leader

By Chris Katje

May 2, 9:38 AM

A leading sports betting operator received shareholder approval for a secondary U.S. listing, which could give investors more opportunities to own a stake in the market leader.

BETZ

4 minute read

Study Asserts CBD Use Can Result In Positive THC Test, Expert Explains How And What Increases Risks

By Nina Zdinjak

May 2, 7:57 AM

Can the consumption of CBD products cause a THC-positive urine test?

CGC